Viral Load Monitoring
Viral Load Monitoring - Related Videos
03:40
Plaque Assay–Based Quantification of Viral Load in an Infected Mouse Tissue Sample
0 Views •
2026
Source: Morales Vasquez, D., et al. Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2. J. Vis. Exp. (2021)This video demonstrates the protocol for carrying out plaque assay–based viral titration for quantifying infectious virus levels in tissue sample collected from a virus–infected mouse model.
02:27
Measuring Hepatitis C Viral Load Using Quantitative Reverse Transcription Polymerase Chain Reaction
0 Views •
2026
Source: Ren, S., et al. A Protocol for Analyzing Hepatitis C Virus Replication. J. Vis. Exp. (2014).This video demonstrates the procedure for quantifying Hepatitis C viral RNA using quantitative reverse transcription PCR to measure viral load in infected cell cultures.
13:58
Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays
0 Views •
Cited by 10 •
2011
Quantifying levels of HIV-1 RNA in plasma and sequencing single HIV-1 genomes from individuals with viral loads below the limit of detection (50-75 copies/ml) is difficult. Here we describe how to extract and quantify plasma viral RNA using a real time PCR assay that reliably measures HIV-1 RNA down to 0.3 copies/ml and how to amplify viral genomes by single genome sequencing, from samples with very low viral loads.
13:45
Using a Pan-Viral Microarray Assay (Virochip) to Screen Clinical Samples for Viral Pathogens
0 Views •
Cited by 83 •
2011
The Virochip is a pan-viral microarray designed to simultaneously detect all known viruses as well as novel viruses on the basis of conserved sequence homology. Here we demonstrate how to run a Virochip assay to analyze clinical samples for the presence of both known and unknown viruses.
14:04
Viral Nanoparticles for In vivo Tumor Imaging
0 Views •
Cited by 45 •
2012
Plant viral nanoparticles (VNPs) are promising platforms for applications in biomedicine. Here, we describe the procedures for plant VNP propagation, purification, characterization, and bioconjugation. Finally, we show the application of VNPs for tumor homing and imaging using a mouse xenograft model and fluorescence imaging.
FAQs
Quantitative nucleic acid amplification tests detect viral RNA or DNA and estimate its amount by comparing the signal from the specimen with calibrated standards. Real-time PCR is one example of this approach. Calibration allows results to be expressed as measurements that can be compared across samples and time, supporting analysis of changing infection dynamics rather than a single isolated observation.
Calibrated standards provide the reference needed to translate nucleic acid detection into a quantitative estimate. Without that reference, a test could indicate that viral genetic material is present but would not provide the same basis for measuring change. Standardized comparison is therefore central to evaluating trends, assessing treatment response, and relating measurements collected at different time points.
Serial viral measurements provide a way to examine how pathogen replication changes as immune control changes. A declining or stable measurement can be considered alongside immunological observations, whereas increasing amounts may indicate greater replication activity. In infection research, this relationship helps investigators study disease progression and how host responses influence the amount of detectable viral genetic material.
The workflow begins with collecting blood or another relevant clinical specimen, measuring viral RNA or DNA with a quantitative nucleic acid amplification test, and recording the resulting value. Repeating the process creates a time series. Clinicians and researchers then compare the measurements across time to evaluate infection dynamics, treatment response, possible rebound, or changing transmission-risk considerations.
Measurements collected before and during antiviral therapy allow the observed viral trend to be assessed rather than relying only on symptoms or a single test. A decreasing result can support evaluation of response, while a later increase may identify virologic rebound. These patterns give clinicians information for ongoing infection management and help researchers study how treatment relates to pathogen replication.
Viral load results contribute to transmission-risk management by showing how the amount of detectable viral genetic material changes during infection. Serial measurements can indicate whether the infection is decreasing, remaining present, or increasing again. They do not replace clinical interpretation, but they provide an objective laboratory trend that can be considered with other information when managing infection and studying spread-related risk.